Article
Prenatal exposure to β2‐adrenoreceptor agonists and the risk of autism spectrum disorders in offspring
19 Apr 2017
Abstract excerpt
PURPOSE: We aimed to examine the risk of autism spectrum disorders (ASDs) in the offspring who were exposed to maternal use of β2-adrenoreceptor agonist (β2AA) during pregnancy. METHODS: This is a population-based cohort study including all live singleton births in Denmark from 1 January 1997 to 31 December 2008. Children born to mothers who used β2AA during pregnancy were categorized as exposed, and all other...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
